China’s infant formula sales up for major players in first half of 2025
Several leading infant formula companies have reported growth in their infant formula sales in China for the first half of this year.
Danone’s Aptamil, Yili, Friesland Campina’s Friso, The a2 Milk Company, and Biostime from H&H Group are some examples that have continued to see growth, amid concerns on fluctuating birth rates in China.
The popularity of premium products and expanding sales in both offline mother-and-baby stores and online channels form a common thread.
Nestle launches tool to screen for diabetes risk in China population
Nestle has launched a screening tool for detecting diabetes risk among the Chinese population.
The tool is available via WeChat Mini Program YiYang, which is also a brand of Nestle’s nutritional products launched in China.
According to Nestle, it complements the company’s range of digital tools for supporting personalized nutrition recommendations.
It is also one of Nestle’s latest initiatives in building its range of products and services for supporting blood glucose management in China.
a2MC doubles down on China label infant formula with new plant purchase
The a2 Milk Company (a2MC) is set to buy a manufacturing facility from Yashili New Zealand in the hopes of ramping up its China label infant formula business.
The company has been seeing sales growth for both its English and China label infant formula in FY25, with the former increased by 17.2% and the latter by 3.3%.
In China, growth was said to be led by effective new user recruitment initiatives, resulting in a record market share of 4% in stage 1 products in the mother-and-baby channels.
BYHEALTH profits down 17%, looks to SEA for new growth
China health supplements giant BYHEALTH has continued to see a decline in its sales and profits, and the company said it would be pumping more resources to grow its international business, especially in South East Asia.
Net profit attributed to shareholders of the company dropped 17.34% to RMB736.5m (US$102.5m), while operating revenue fell 23.43% to RMB 3.5bn (US$491.7m).
A continually fragmented retail landscape was said to be one of the reasons for the decline.
Calcium, protein the most used supplements among China centenarians
Calcium and protein were the most used health supplements among China centenarians, according to a study involving over 2,800 centenarians.
According to findings published in Geroscience, about one in 10 Chinese centenarians used dietary supplements.
The prevalence was higher in men, with 12.3% of male centenarians taking health supplements, as compared to 10.7% among females.
